Eli Lilly is partnering with Walmart to offer Zepbound through its direct-to-consumer program, making the popular medication ...
With a new generation of weight-loss drugs entering Indian markets, spelling hope for many, The Indian Express tracks the ...
Pfizer has filed a lawsuit against Metsera and Novo Nordisk, saying Metsera breached its merger agreement obligations.
Amid wider economic uncertainty, some analysts have said that businesses are at a “no-hire, no fire” standstill.
Up to 5,000 people in Scotland will take the injections as part of a multi-million pound study being led by Glasgow University.
Pfizer is suing over some unsolicited competition in its nearly $5 billion bid to buy the drugmaker Metsera. New York-based Pfizer said Friday after markets closed that it was suing Metsera and a ...
A trial funded by the Labour Government will ensure obese Scots have free access to Wegovy medication that can cost over £100 ...
Scripps Research in La Jolla announced a new clinical trial Thursday that will assess the effectiveness of using drugs approved for diabetes treatment and weight loss to treat long COVID, the ...
Pfizer has decided to sue Metsera and Novo over $8.5B bid, citing antitrust risks and asserting regulatory advantage.
The market for obesity and diabetes treatments remains scorching hot, funneling billions in sales to Eli Lilly and fueling a bidding war over another drugmaker.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results